2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts
|
|
- Brittany Maria Maxwell
- 6 years ago
- Views:
Transcription
1 2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 116 USP <797> Update 2008 and Personnel-Related Environmental Sampling Trissel, L.A. TriPharma Research, P.O. Box 265, Cashiers, NC 28717, USA. Kastango, E.S. Abstract: The United States Pharmacopeia (USP) has published revisions to USP Chapter <797>, the national quality standards for sterile compounding. The revised quality standards become the current standard as of June, This presentation provides an overview of the content of the USP Chapter <797> with a focus on the new and changed standards to aid practitioners in understanding and interpreting the needed quality assurance measures to protect patients from erroneous and contaminated sterile compounded preparations. Chapter <797> contains standards that begin with defining the responsibilities of compounding personnel. The Chapter also includes discussion and description of various quality assurance steps involving environmental control and monitoring, quality testing of compounded dosage forms, personnel aseptic technique evaluation, determination of product risk, storage and beyond use dating, topics for standard operating procedures, and more. The presentation will focus on these quality assurance components that need to be considered and addressed to safely provide compounded sterile products for use in patient care. Learning Objectives: 1. Outline recent revisions of USP Chapter <797> requirements. 2. Explain the rationale for many of the changed standards. 3. Explain the implications for pharmacists of changes in USP chapter <797> standards. 4. Describe five principal new sections of USP Chapter <797> needed to achieve USP chapter <797> compliance for compounding sterile preparations. Self-Assessment Questions: 1. The revisions to the quality standards of USP Chapter <797> are few in number and minor in nature. a. True
2 2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts b. False 2. Sterile drugs compounded according to the Immediate Use category requirements: a. Allow home care pharmacies get around the quality requirements of <797>. b. Are for use within 1 hour after the start of compounding. c. Eliminate the need for a laminar airflow hood or isolator for compounding parenteral nutrition (TPN and TNA) admixtures. d. May not be stored overnight for use the next day after compounding. e. Both b and d. 3. For hazardous drugs, such as cancer chemotherapy: a. Compounding must be performed in biological safety cabinets or compounding aseptic containment isolators vented to the outside and located in a separate negative airflow ISO 7 buffer room. b. Closed-system vial transfer devices provide a suitable substitute for biological safety cabinets and compounding aseptic containment isolators. c. The requirements of <797> for hazardous drugs are to be followed no matter how few doses are compounded. d. Personal protective garb is not needed if a biological safety cabinet is used. 4. USP Chapter <797> specifies the cleaning and disinfection frequencies of sterile compounding facilities. Which of these cleaning and disinfection frequencies is incorrect? a. Floors daily. b. Biological safety cabinets, laminar airflow workbenches, and compounding aseptic isolators daily. c. Work counters daily. d. Walls and storage shelves monthly. e. Ceilings monthly. 5. For compounding aseptic isolators (CAIs), which of the following are correct? a. Placement in an ISO class 7 buffer room may be needed depending on the CAI design and functionality. b. Personnel protective garb may be required unless the CAI manufacturer has proven that the garb is unnecessary.
3 2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts c. CAIs must be validated at the use site to maintain an ISO class 5 environment under dynamic (in-use) working conditions. d. CAIs must maintain unidirectional airflow at the critical sites. e. All of the above Answers: 1. b; 2. e; 3. a; 4. b; 5. e
4 ASHP 2008 Summer Meeting Seattle, WA 10 June, 2008 Understand the personnel-related changes of the revised USP Chapter <797> Eric S. Kastango, MBA, RPh, FASHP Clinical IQ, LLC Florham Park, NJ Disclaimer Although I am a member of the USP Sterile Compounding Committee, I am speaking in my individual capacity and not as a member of the Committee or as a USP representative. The views and opinions presented are entirely my own. They do not necessarily reflect the views of USP, ASHP or any other organization, nor should they be construed as an official explanation or interpretation of <797>.
5 Systems Thinking It must be remembered that there is nothing more difficult to plan, more doubtful of success, not more dangerous to manage than the creation of a new system; for the initiator has the enmity of all who would profit by the preservation of the old institution and merely lukewarm defenders in those who would gain by the new one. Machiavelli The Prince 1513 Leadership Responsibilities Pharmacy is a profession. Despite the challenges to professionalism presented by changes in healthcare, pharmacists must embrace the responsibilities that stem from their profession s guiding principles. ASHP Statement on Professionalism. Am J Health-Syst Pharm. 2008; 65:172-4 Believe in what is expected from employees and ensure that employees understand what is expected of them from you! Being a change agent is one of the most difficult thing you can be asked to do. The principles of USP <797> is not difficult, changing peoples attitudes and beliefs about compounding what is hard and requires great leadership.
6 Leadership Responsibilities Examine the system and monitor for failures Audit critical activities Remove the system failure in order to uncover the human errors Provide feedback Find employees doing things right Address deviations in the process or procedure Retrain Discipline Action Attitude Attitude towards compliance, following the rules and being vigilant will ultimately determine the success or failure of any program, especially aseptic compounding Regardless of Primary and Secondary Engineering Controls used, inappropriate and improper employee work practices and activities can result in contaminated CSPs
7 Responsibility of Compounding Personnel Compounding personnel are: Adequately skilled, educated, instructed, and trained to correctly perform and document the following activities in their sterile compounding duties Perform antiseptic hand cleansing and disinfection of nonsterile compounding surfaces Select and appropriately don protective garb Responsibility of Compounding Personnel Maintain or achieve sterility of CSPs in ISO Class 5 primary engineering devices and protect personnel and compounding environments from contamination by radioactive, cytotoxic, and chemotoxic drugs. Identify, weigh, and measure ingredients. Manipulate sterile products aseptically, sterilize high risk level CSPs, and label and quality inspect CSPs.
8 Hand Hygiene Hand washing is defined as the vigorous, brief (30 seconds) rubbing together of all surfaces of lathered hands, followed by rinsing under a stream of water. Hand washing suspends microorganisms and mechanically removes them by rinsing with water. The fundamental principle of hand washing is removal, not killing. Single most important way to reduce the risks of transmitting germs. Even after using anti-microbial soap, there is still about 20,000 microbes per sq mm.
9 Definitions Hand hygiene Performing handwashing, antiseptic handwash, alcohol-based handrub, surgical hand hygiene/antisepsis Handwashing Washing hands with plain soap and water Antiseptic handwash Washing hands with water and soap or other detergents containing an antiseptic chemical agent Alcohol-based handrub Rubbing hands with an alcohol-containing preparation Surgical hand hygiene/antisepsis Handwashing using an alcohol-based surgical scrub with persistent activity (Sterile compounding of preparations and the performance of a surgical procedure are considered in the same league together) Guideline for Hand Hygiene in Health-care Settings. MMWR 2002; vol. 51, no. RR-16. Hand hygiene 1 is paramount to safety, as this agar imprint of an unwashed hand shows E Larson. Am J Nurs, AJN. July 1989:935.
10 Efficacy of Hand Hygiene Preparations in Killing Bacteria Good Better Best Plain Soap Antimicrobial soap Alcohol-based handrub Ability of Hand Hygiene Agents to Reduce Bacteria on Hands % 99.9 Time After Disinfection log minutes 3.0 Bacterial Reduction Alcohol-based handrub (70% Isopropanol) Antimicrobial soap (4% Chlorhexidine) Plain soap Baseline Adapted from: Hosp Epidemiol Infect Control, 2 nd Edition, 1999.
11 Environment vs. Personnel The most important variable affecting microbial contamination of admixtures was the aseptic technique of personnel, not the environment in which the drugs were compounded. Thomas M, Sanborn M, Couldry R. I.V. admixture contamination rates: Traditional practice site versus a class 1000 cleanroom. Am J Health- Syst Pharm 2005;62: Compounding Personnel A human person in a cleanroom is considered a broad spectrum particle generator enclosed by inefficient mechanical filters which may also be sources of particles The human body harbors an average of different classes of bacteria Hands have an average of 100,000 organisms / sq mm The body sheds 5 grams of skin fragments each day along with shedding 1 layer of skin every 5 days (size range 10 to 300 micron 1000 th of a mm) Our greatest asset and also our biggest liability!
12 Inherent Particles Present in Cleanrooms Activity Person emits during garmenting process Particles 0.3 μm 3,000,000/min Cleanest skin (hands) 10,000,000/ft 2 Employee street clothes 10,000,000 30,000,000/ft 2 Floor and bench surfaces > 10,000,000/ft 2 Garments supplied by cleanroom laundry 1,000,000/ft 2 Kastango ES, Bradshaw B, AJHP Sept 15. Sources of Microbial Contamination in Aseptic Processing* Source Personnel Human error Aseptic assembly Non-routine activity Mechanical failure Airborne contaminants Improper sanitization Surface contaminants 0.2 μm filter failure HEPA failure Ranks *GallocoJ, Akers J, MadsenR. Aseptic Processing: A Review of Current Industry Practice. Pharmaceutical Technology. 2004; 28(10, Oct):128.
13 Garbing requirements Garb requirement Immediateuse Low Risk (12 hr) Med Risk High Risk Makeup/Jewelry restrictions N Hand washing Hair/facial cover N Shoe covers N Low-shed gown N Sterile Gloves N Masks N
14 Employee hand hygiene and garbing Unacceptable practices Employee hand hygiene and garbing Unacceptable practices
15 Employee hand hygiene and garbing Proper Gowning Guidelines Dress from head down Dirty to Clean (head, face and feet) Wash Hands Gown Persistent Antimicrobial Hand Scrub Sterile Gloves and Sterile Alcohol Understand garment design Know how to seal gaps between clothing (closed at the neck and elastic cuffs) Perform final inspection (in mirror or others) Minimize motion Walking in street cloths generates millions of particles
16 Compounding Personnel Hair net Beard cover and face mask Gown Nonsterile Gloves Sterile Shoe covers Aseptic Technique Most critical element to prevent CSP contamination is directly related to employee aseptic technique and proper disinfection practices
17 USP 797 and Particulates Why such an emphasis? Dust Particles Breach of Aseptic Technique Contamination + = Microbes ride dust and particulates Particles with microbes infiltrate CSP Microbes grow within CSP Implication 2: Since you never get 0 particulate, proper aseptic technique controls the rest of contamination risk Implication 1: Control particulate, you reduce downstream contamination risk substantially Images courtesy ClinicalIQ, LLC. Principle of First Air Good aseptic technique in sterile compounding requires the understanding and proper use of First-Air. First-Air is the air exiting the HEPA filter in a unidirectional airstream and is virtually free of particulate contaminants. All critical manipulations must be carried out in the unobstructed first air zone in the direct path of the HEPA filter discharge. Proper product and process placement with respect to the supply and discharge will provide a contamination free compounding area. 2006, Clinical IQ, LLC and Controlled Environment Consulting Zone of first-air Simulated with smoke to show airflow
18 Direct Compounding Area (DCA) First Air 2006, Clinical IQ, LLC and Controlled Environment Consulting The DCA is only the portion of the PEC dedicated to the task of aseptic manipulation. Second Air 2006, Clinical IQ, LLC and Controlled Environment Consulting Improper hand placement disrupts first air
19 First Air 2006, Clinical IQ, LLC and Controlled Environment Consulting Proper hand placement permits first air Training and Evaluation Compounding personnel shall perform didactic review and pass written test and media-fill testing of aseptic manipulative skill initially. At least annually thereafter for low- and medium-risk compounding. At least semiannually for high-risk level compounding. Consider performing routine observational audits of employee work practices Document observational audits
20 Evidence-based science An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU. N Engl J Med 2006;355: An evidence-based intervention resulted in a large and sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintained throughout the 18- month study period. The average infection rate fell from 7.7 percent to 1.4 percent after 18 months. 'More than half the hospitals (103) in this study were able to report that they had ZERO infections after implementing the program,' Consistent and vigilant work practices were key factor: Assuring that participants wash their hands before the procedure. Assuring full barrier protection -- a sterile bed sheet rather than just keeping the insertion site sterile, Staff wear sterile gloves, gowns, hair nets and masks. Cleansing the skin surface with chlorhexidine. Environmental Sampling Environmental Sampling Task Dilemma: One of the most contentious section of USP Chapter <797> Since 1970 s, the US Centers for Disease Control (CDC) has not advocated routine viable environmental monitoring The US Food and Drug Administration requires sterile processing operations to perform daily monitoring of viable air, surface and personnel glove fingertip samples
21 Environmental Sampling Routine Viable Microbial Environmental Monitoring (EM) None Daily US Centers for Disease Control US Food and Drug Administration Environmental Monitoring None Routine Viable Microbial Environmental Monitoring (EM) USP 797 Daily US Centers for Disease Control US Food and Drug Administration
22 Environmental Monitoring Environmental Monitoring section has been separated into a facility-related performance metric and a personnel related performance metric Facility-related Environmental Sampling Viable air samplingvia volumetric method (impaction) to occur at least every 6 months Personnel-related Environmental Sampling Personnel fingertip sampling during initial training, with media fills and as a competency assessment tool Surface sampling for viable microorganisms Environmental Sampling: Viable Air Sampling Collection method via electric volumetric sampler (impaction preferred method) Gravimetric methods (e.g., plates or paddles) are not permitted Growth media: TSB and MEA (when high-risk compounding) Sampling plan developed and based on a risk assessment of compounding activities Sampling locations to include: Each ISO Class 5 Engineering Control Area in ISO Class 7 and 8 and segregated areas and around ISO Class 5 area at greatest risk (e.g., pass-thru, labeling, staging, gowning areas)
23 Environmental Sampling: Viable Air Sampling Sampling plan to include: Method of collection (Impaction preferred method) Frequency of testing Volume of air sampled ( L) Time of day and activity of compounding CFUs action levels Frequency of testing Initial facility commissioning At least every six months during recertification of facility and engineering controls of all areas Reference: USP <1116>: Microbiological Evaluation of Clean Rooms and Other Controlled Environments Environmental Monitoring Viable Air Sampling Gravimetric vs. Volumetric Sampling Courtesy of MSI, Inc. Houston, TX (
24 Environmental Sampling: Employee-centric Activities The risk of contaminating a CSP prepared under low-risk level and medium-risk level conditions is highly dependent on: Proper hand hygiene and garbing practices, Compounding personnel aseptic technique, and Presence of surface contamination Assumes all work is performed in a certified and properly functioning ISO Class 5 Environmental Sampling: Employee-centric Activities Compounding personnel shall: Complete didactic training, Pass written competence assessments, Undergo skill assessment using observational audit tools (see Appendices III V) Garbing and Gloving Competency Evaluation Aseptic Manipulation Competency Evaluation Cleaning And Disinfecting Competency Evaluation Successfully complete aseptic media fill testing
25 Environmental Sampling: Gloved Fingertip Sampling Initial training assessment with audit tool Successful gloving with three-time fingertip sampling with ZERO CFUs Annually re-assessment for low and medium-risk compounding operations Semi-annual re-assessment for high-risk compounding operations During any media fills Environmental Sampling: Surface Surface Cleaning and Disinfection Sampling and Assessment Surface sampling is an important component of the maintenance of a suitable microbially controlled environment Transfer of microbial contamination from improperly disinfected work surfaces via inadvertent touch contact by compounding personnel can be a potential source of contamination of CSPs It is useful for evaluating facility and work surface cleaning and disinfecting procedures and employee competency in work practices such as disinfection of component/vial surface cleaning.
26 Environmental Sampling: Surface Surface Cleaning and Disinfection Sampling and Assessment Sampling of all ISO classified areas will occur on a periodic basis at the end of compounding Contact plates (plate size cm 2 ) Swabs (defined template) Plates to have a neutralizing agents (lecithin and polysorbate 80) Environmental Sampling: Cleaning Cleaning And Disinfecting Competency Evaluation Compounding personnel and other personnel responsible for cleaning shall be visually observed during: Performance of cleaning and disinfecting procedures During initial personnel training on cleaning procedures During changes in cleaning staff, At the completion of any media-fill test procedure Visual observation documented on Sample Form (Appendix V)
27 Integration of Policy into Practice Where do we begin? How do we begin? How do we ensure success? How do we measure success? Integration of Policy into Practice Where do we begin? Identify the desired state of being What is driving this desired state of being? Resources (Fiscal, Human or other) Regulatory In response to an event What do want our process to look it but more importantly What is our desired outcome from our policy?
28 Integration of Policy into Practice How do we begin? Must involve all employees who will have an affect, contribution or influence over the system Employees must be process owners and buy into the desired state The creation of shared vision or model is critical Try to identify all the roadblocks to success Optimize the system! Termite Hill Can t be reduced to the termites Statistically emergent from termite By the way there is no CEO termite or DOP termite etc., just termites that all know their places and tasks in the system We establish order and control through actions of a few top people in the organization this may be the biggest factor holding back innovation and progress in our organizations
29 Integration of Policy into Practice How do we measure success? Look carefully for workarounds, shadow aids, and other deviations Indicators of attempts to bridge gaps in performance Non-threatening observations of real work give voice to the unvoiced Give feedback (positive and negative) and demonstrate leadership People respect what we inspect! Try not. Do, or do not. There is no try. -Master oda
Sterile Compounding Safety
Sterile Compounding Safety I International Congress on Patient Safety ISMP Brazil and V International Forum on Patient Safety: Medication Errors Eric S. Kastango, MBA, RPh, FASHP President/CEO Clinical
More informationCompounding Aseptic Isolators (CAI) James T Wagner
Compounding Aseptic Isolators (CAI) James T Wagner jimwagner@cenvironment.com Disclaimer "Although I am a member of the USP Sterile Compounding Expert Committee, I am speaking today in my individual capacity
More informationWho says you re competent?
Who says you re competent? Eric Kastango MBA, RPh, FASHP ClinicalIQ, LLC eric.kastango@clinicaliq.com, www.clinicaliq.com http://www.linkedin.com/in/erickastango 1 Disclaimer Although I am a member of
More informationSterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)
Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE CriticalPoint s Sterile Compounding elearning curriculum is written by industry experts and covers both Chapter and
More informationUSP <797> Compliance Common Challenges and Potential Solutions
USP Compliance Common Challenges and Potential Solutions Angela Yaniv, Pharm.D Assistant Director - Sterile Products May 2, 2017 - OSHP Annual Meeting Angela Yaniv has no actual or potential conflict
More informationPharmacy Quality Assurance Commission Sterile Compounding [USP <797>] Self-Assessment Compliance Checklist
STATE OF WASHINGTON Pharmacy Quality Assurance Commission Sterile Compounding [USP ] Self-Assessment Compliance Checklist Introduction: This checklist includes the reported principal competencies,
More informationUSP <797> : IP + Pharmacist as partners in Medication Safety
USP : IP + Pharmacist as partners in Medication Safety Presented by: Keith H. St. John, MS, CIC Director, Clinical Epidemiology Wolters Kluwer Health Sentri7 Clinical Solutions Disclosures "Although
More informationUNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL CLEANROOMS
DEPARTMENT OF VETERANS AFFAIRS Veterans Health Administration Washington DC 20420 IL 10-2006-008 In Reply Refer To: 10NB UNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL
More informationHistory and Update of Chapters 797 and 800
United States Pharmacopeia (USP) History and Update of Chapters 797 and 800 Lisa D. Ashworth, BS Pharm, RPh, FACA 50 th Annual C.E. Seminar Saturday, January 27, 2018, Dallas, Texas Disclaimer The views
More informationBRIEFING 797 PHARMACEUTICAL COMPOUNDING STERILE PREPARATIONS INTRODUCTION
1 of 58 8/20/2010 9:20 PM BRIEFING 797 Pharmaceutical Compounding Sterile Preparations, USP 32 page 318. As a result of frequently asked questions from compounding practitioners and continuous reassessment
More informationUSP<797> AND THE ASEPTIC PROCESSING OF RADIOPHARMACEUTICALS PART 1
USP AND THE ASEPTIC PROCESSING OF RADIOPHARMACEUTICALS PART 1 INTRODUCTION The learner was introduced to the guidelines of USP Chapter in a previous Continuing Education lesson, USP Compliance
More informationMicrobiological Consideration for Non-Sterile Pharmaceutical
May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control
More informationGuidelines for Design of. Compounded Sterile Products (CSPs) Facility
State of Kuwait Ministry of Health Infection Control Directorate Task Force Group for Designs and Constructions of Health Care Facilities Guidelines for Design of Compounded Sterile Products (CSPs) Facility
More informationUSP <797> and Environmental Sampling
USP and Environmental Sampling Participants will be in listen only mode. 9 a.m. (PT) Download the PDF: https://www.emlab.com/m/media/usp797-webinar.pdf Presented by: Michael Berg, Ph.D. Continuing
More informationUSP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
More informationFacility Design for Pharmacy Operation. Full-Scale Nuclear. Slides are not to be reproduced without permission of author.
Facility Design for Pharmacy Operation Full-Scale Nuclear in a Hospital Setting Neil A. Petry, MS, RPh, BCNP, FAPhA Clinical i l Assistant t Professor in Radiology Director, Radiopharmacy Services Duke
More informationFDA s Guidance for Industry
Sterile Drug Products Produced by Aseptic Processing - CGMPs Midwest FDC Conference November 4 2005 Susan Bruederle, Investigator FDA / ORA / Central Region Chicago District / Hinsdale IL FDA s Guidance
More informationLUNCH AND LEARN. October 14, CE Activity Information & Accreditation
LUNCH AND LEARN USP Chapter : What s on the Radar? October 14, 2016 Featured Speaker: Patricia C. Kienle, RPh, MPA, FASHP Director, Accreditation and Medication Safety Cardinal Health Innovative Delivery
More informationPHCT 401 Aseptic Processes & Techniques
PHCT 401 Aseptic Processes & Techniques Principles of Aseptic Techniques Aseptic Processing Sterility Testing Laminar flow air cleaning Quality Control Tests Personnel Principles of Aseptic Techniques
More informationFLORIDA SOCIETY OF HEALTH SYSTEM PHARMACISTS NOVEMBER 4, 2016 JAMES T WAGNER CONTROLLED ENVIRONMENT CONSULTING
Engineering Controls for Compliance with USP Chapters and FLORIDA SOCIETY OF HEALTH SYSTEM PHARMACISTS NOVEMBER 4, 2016 JAMES T WAGNER CONTROLLED ENVIRONMENT CONSULTING Learning and Performance
More informationfor IND and RDRC Regulated PET Compounding
Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials SNM, Annual Meeting Toronto, Ontario, Canada
More informationImportant Updates in USP <797> and USP <823> Eric S. Kastango, MBA, BS Pharm, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison, New Jersey
Important Updates in USP and USP Eric S. Kastango, MBA, BS Pharm, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison, New Jersey Disclosures Principal-Clinical IQ, LLC Healthcare consulting
More informationPhEn-602 Notes # 4 J. Manfredi
PhEn-602 Notes # 4 J. Manfredi Spring 2009 1 Basic definitions Clean Room: A room in which the concentration of airborne particles is controlled and contains one or more clean zones Clean Zone: A defined
More informationMINIMUM REQUIREMENTS FOR A VENDOR
MINIMUM REQUIREMENTS FOR A VENDOR When outsourcing the production of sterile products the first step in vendor evaluation is to see if they meet the minimum requirements. We ve developed a group of questions
More informationPharmacy Compounding: Infection Prevention
Pharmacy Compounding: Infection Prevention Sam Eberwein, PharmD, MS, BCPS Clinical Manager, Sterile Products Area, Perioperative Services, & Special Formulations UNC Medical Center Department of Pharmacy
More informationOverview of a sterility assurance program for PET drugs
Coalition for PET Drug Approval Radiopharmaceutical Sciences Council Overview of a sterility assurance program for PET drugs Eric Webster, PETNET Solutions Disclosures Employee of PETNET Solutions, a Siemens
More informationThanks and acknowledgement to Pamela Isaacs for the content and slides in this presentation.
A PRESCRIPTION FOR INFECTION PREVENTION ROUNDING IN THE PHARMACY EVELYN COOK Thanks and acknowledgement to Pamela Isaacs for the content and slides in this presentation. OBJECTIVES: 1. Discuss recent outbreaks
More informationChapter WAC Compounding Practices Crosswalk
Chapter 246-878 WAC Compounding Practices Crosswalk Draft WAC Language WAC 246-878-001 Purpose. 1) The requirements of this chapter apply to any person or facility that possesses a license under 18.64
More informationá797ñ PHARMACEUTICAL COMPOUNDING STERILE PREPARATIONS
626 á795ñ Pharmaceutical Compounding Nonsterile / Physical Tests USP 39 Vehicle: A component for internal or external use that is used as a carrier or diluent in which liquids, semisolids, or solids are
More informationQuality is Our Promise.
Quality is Our Promise. Our goal at KRS Global Biotechnology is to provide the highest quality pharmaceutical preparations. We accomplish this with an unrivaled quality assurance and quality control program
More information2008 USPC Official 5/1/08-7/31/08 General Chapters: <797> PHARMACEUTICAL... Page 1 of PHARMACEUTICAL COMPOUNDING STERILE PREPARATIONS
2008 USPC Official 5/1/08-7/31/08 General Chapters: PHARMACEUTICAL... Page 1 of 46 797 PHARMACEUTICAL COMPOUNDING STERILE PREPARATIONS INTRODUCTION This chapter provides procedures and requirements
More informationHospital Pharmacy Isolator Solutions for USP <797> Compliance from Esco
Hospital Pharmacy Isolator Solutions for USP Compliance from Esco Contents 1. Introduction 2. Clean Air Devices and Isolators 3. Cytotoxic Exposure 4. Esco Pharmacy Isolator (Positive Pressure Model)
More informationMeeting of the Minds: Pharmacy Services and Integration
Meeting of the Minds: Pharmacy Services and Integration RICK ABBOTT- B.Sc (Pharm) Regional Pharmacy Manager, Systemic Therapy, Eastern Health, Pharmacy Services CAROLE R. CHAMBERS- B.Sc (PHARM), MBA Pharmacy
More informationThis compilation of the complex
Manufacturing in a Global Marketplace Reference Matrices on Regulations for Classified (Environmentally Controlled) Areas Betty Seawell, William Miele, and Jean Huxsoll The complex world of international
More informationUSP 797 & 800 Pharmacy Overview. (Presented to Vermont Chapter of New England Healthcare Engineers May 2016)
USP 797 & 800 Pharmacy Overview (Presented to Vermont Chapter of New England Healthcare Engineers May 2016) Overview Background and Regulatory Need United States Pharmacopeia (USP) 797 Purpose/Goals USP
More informationUSP Chapter <797>: De-mystifying Beyond-Use Dating. Eric S. Kastango, MBA, RPh, FASHP Clinical IQ, LLC Florham Park, NJ
USP Chapter : De-mystifying Beyond-Use Dating Eric S. Kastango, MBA, RPh, FASHP Clinical IQ, LLC Florham Park, NJ Special Thanks David W. Newton, PhD, FAPhA for his tutelage and forbearance regarding
More informationBioburden Contamination Control: A Holistic Overview
Bioburden Contamination Control: A Holistic Overview Scott Sutton, PhD Microbiology Network, Inc. Scott Sutton, PhD is the Principal of Microbiology Network, Inc (http:// microbiologynetwork.com/) a company
More informationIsolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite
APV 2008 Basle Conference Basle, Switzerland: May 28 & 29 2008 Isolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite John R. Chester Principal Engineer Global Pharmaceutical
More informationFull Contact Details:
Comment Submission Template for: General Chapter Pharmaceutical Compounding Sterile Preparations Revision proposed in Pharmacopeial Forum 41(6) Nov/Dec 2015 Send completed template to CompoundingSL@usp.org
More informationPolicies Concerning Survival Surgery of Mice
Policies Concerning Survival Surgery of Mice Date approved: October 25, 2016 Purpose This document details the minimum standards for survival (recovery) surgery in all laboratory rodent species. Responsibility
More informationUSP <800> A practical approach to compliance. Ryan W. Naseman, PharmD, MS, BCPS Michael Storey, PharmD, MS, BCPS
USP A practical approach to compliance Ryan W. Naseman, PharmD, MS, BCPS Michael Storey, PharmD, MS, BCPS Learning Objectives Explain the need for USP from an employee safety standpoint Describe
More informationMICROBIOLOGICAL CULTURE MEDIA
MICROBIOLOGICAL CULTURE MEDIA A COMPLETE GUIDE FOR PHARMACEUTICAL AND HEALTHCARE MANUFACTURERS Tim Sandle Microbiological Culture Media: A Complete Guide for Pharmaceutical and Healthcare Manufacturers
More informationStudy Summary. Results: All tested media-filled vials were negative for growth of any microorganisms.
A 7 Days Microbial Ingress Test of Single Use Vials Utilizing the EQUASHIELD Closed System Drug Transfer Device Study by Nelson Laboratories (Salt Lake City, UT) 2013, updated in 2014* Study Summary Abstract:
More informationBest Practices for High Level Disinfection Part I
Best Practices for High Level Disinfection Part I Nancy Chobin, RN, AAS, ACSP, CSPM, CFER 2017 Sterile Processing University, LLC. **This in-service has been Approved by the CBSPD for 1.5 CEUs. The Bible
More informationEnvironmental Monitoring of Aseptic Processing Areas - 1
Environmental Monitoring of Aseptic Processing Areas - 1 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Training Course Agenda Overview of Environmental Monitoring
More informationInspection Checklist for NIH BL3 Laboratories (7 CFR 331; 9 CFR 121; 42 CFR 73; NIH Guidelines)
12(a) 12(a) 12(b) 12 (c)(3) An individual or entity required to register under this part must develop and implement a written biosafety plan that is commensurate with the risk of the agent or toxin, given
More informationWhere Quality Meets Flexibility
Where Quality Meets Flexibility is an industry leading 503B Outsourcing Facility providing sterile and non-sterile compounding services to hospitals, surgery centers, clinics, researchers & patients nationwide.
More informationContamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC
Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC Contamination risk levels differ in aseptic, and non-sterile and terminally sterilized
More informationCompounding Pharmacies and Water
Compounding Pharmacies and Water Scott Sutton, PhD scott.sutton@microbiol.org August 21, 2014 46 Disclaimer I am an independent consultant. I have been involved with USP for many years. I do not represent
More informationInspection Form. DPP Information. Inspection Information. Staff Information. Service Information. DPP Designated Member. Street City Postal Code
Inspection Form DPP Information Name of DPP Owner Name of DPP (if different from owner's name) DPP Designated Member Designated Member Email Designated Member Phone number Street City Postal Code Phone
More informationSafe to Handle? Comparing Manually and Machine-Washed Medical Devices
Safe to Handle? Comparing Manually and Machine-Washed Medical Devices Kaumudi Kulkarni, Dzelma Kaczorowski, Alex Bonkowski, Stephen Kovach, and Ralph Basile About the Authors Kaumudi Kulkarni, MS, is manager
More informationUSP <1116> and Contamination
USP and Contamination Recovery Rates Scott Sutton ABSTRACT United States Pharmacopeia (USP) "Microbiological Control and Monitoring of Aseptic Processing Environments" approaches analysis
More informationSFHPHARM18 - SQA Unit Code FA2L 04 Prepare aseptic products
Overview This standard covers the preparation of aseptic products including preparing the environment and self. It covers aseptic preparation for both dispensing and manufacturing. Your practice will be
More informationPreparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014
Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls
More informationMedia Fill A Process Simution. Presented By Shikha Chauhan
Media Fill A Process Simution Presented By Shikha Chauhan 21 CFR 211.113 Validation of Aseptic Processing and Sterilization Process Simulation / Media Fill Filtration Efficacy Sterilization of Equipment,
More informationTests to Support Sterility Claim. Imtiaz Ahmed
Tests to Support Sterility Claim Imtiaz Ahmed Sterile Product As per TGO 77, a sterile product must comply with the requirements of the following tests: Sterility Test Bacterial Endotoxins Test Appendix
More informationMicrobiology Research Associates
2017 Microbiology Research Associates List of Services www.mra-bact.com 33 Nagog Park Acton, MA 01720 978.263.2624 Page 1 of 11 Microbiology Tests Pharma/Biotech/Medical Devices Time From Sample Receipt
More informationProfiles in CSP Insourcing: Scripps Health
Profiles in CSP Insourcing: Scripps Health Robert Eastin, Pharm.D. Director, Central Pharmacy and Shared Services Scripps Health Hospital Profile Scripps Health is a private, nonprofit integrated health
More informationUS Regulatory Requirements: Clinical & Clinical Research Production, SPECT & PET Radiopharmaceuticals (RPs)
US Regulatory Requirements: Clinical & Clinical Research Production, SPECT & PET Radiopharmaceuticals (RPs) 20 th International Symposium Radiopharmaceutical Sciences Jeju, Korea Pre-Symposium Workshop
More informationDecember 2009 CDC-NIH
December 00 CDC-NIH Guidelines for Biosafety Laboratory Competency, CDC and the Assocation of Public Health Laboratories, CDC MMWR Supplement/Vol. 60 April, 0 PI: BSL BMBL th Edition CDC-NIH Dec. 00 N/A
More informationTechnical Report No. 70 Fundamentals of Cleaning and Disinfection Programs for Aseptic Manufacturing Facilities
Technical Report No. 70 Fundamentals of Cleaning and Disinfection Programs for Aseptic Manufacturing Facilities PDA Fundamentals of Cleaning and Disinfection Programs for Aseptic Manufacturing Facilities
More informationAntimicrobial Surfaces to Prevent Healthcare-Associated Infection
Antimicrobial Surfaces to Prevent Healthcare-Associated Infection Matthew P. Muller, MD, PhD, FRCPC Medical Director, Infection Prevention and Control, St. Michael s Hospital Chair, Provincial Infectious
More informationGuidelines for the Use of Cytotoxic or Chemotherapeutic Drugs
Guidelines for the Use of Cytotoxic or Chemotherapeutic Drugs Caltech Environment, Health and Safety 1200 E. California Blvd. M/C 25-6 Pasadena, CA 91125 626.395.6727 safety@caltech.edu www.safety.caltech.edu
More informationAseptic Process Validation
Aseptic Process Validation IMB GMP Information Seminar 27 th September 2012 Gerard Sheridan, Inspector Date Insert on Master Slide Slide 1 Overview Guidance Best Practices Common Deficiencies Slide 2 Aseptic
More informationAnnex A2. Guidance on Process Validation Scheme for Aseptically Processed Products
Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products 1 Table of content 1 PURPOSE... 3 2 SCOPE... 3 3 GENERAL INFORMATION... 3 4 INFORMATION NEEDED FOR ASEPTIC PROCESSES VALIDATION...
More informationManaging Aseptic Interventions
Managing Aseptic Interventions James Agalloco This article outlines a comprehensive approach for organizing a firm s aseptic operations, including planning for routine and nonroutine interventions, establishing
More informationEvaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen
Evaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen Edited by: Michael Diamond Reviewed by: Andrew Duong Disclaimer: The author of this report and declare no conflict of interest with
More informationINFECTION CONTROL ISSUES IN CONSTRUCTION AND RENOVATION
INFECTION CONTROL ISSUES IN CONSTRUCTION AND RENOVATION Evelyn Cook SPICE.unc.edu 919 966 1304 I want to begin with the premise that patients can leave the hospital sicker than they arrived if construction
More informationValidation Study on How to Avoid Microbial Contamination during Pharmaceutical Production
Biocontrol Science, 2015, Vol. 20, No.1, 1 10 Review Validation Study on How to Avoid Microbial Contamination during Pharmaceutical Production HIDEHARU SHINTANI 1-13-27, Kasuga, Bunkyo, Tokyo 112-0003,
More informationAnimal Facility Biosafety Level 3 Checklist (date: April 16, 1998)
Date: Location: Responsible: Project Title: Inspector: _ Animal Facility Biosafety Level 3 Checklist (date: April 16, 1998) These questions are based on the Biosafety Level 3 section of Biosafety in Microbiological
More informationWhen Quality Matters. Microbial Air Samplers: Selection Criteria in Biopharma Manufacturing. Celebrating Over 50 Years In Business!
When Quality Matters Celebrating Over 50 Years In Business! Microbial Air Samplers: Selection Criteria in Biopharma Manufacturing Rev. 1.0 (Jan 2016) 1 Doc No.: TN-160104-1 Printed: January 4, 2016 Copyright
More informationMicrobiological Cleaning Method Validation
Microbiological Cleaning Method Validation The purpose of cleaning procedures should never be to reduce bioburden to an acceptable level! Fergus O Connell QA Manager Eurofins ams Laboratories www.eurofins.com
More informationControlled environments
AS 2252.5:2017 AS 2252.5:2017 Controlled environments Part 5: Cytotoxic drug safety cabinets (CDSC) Design, construction, installation, testing and use This Australian Standard was prepared by Committee
More informationWhitepaper. High temperature HEPA filtration. Dr.-Ing. Marc Schmidt, Dr.-Ing. Lothar Gail, Hugo Hemel MSc. Preview
High temperature HEPA filtration Air filtration challenges and answers for dry heat sterilization tunnels Whitepaper Preview Dr.-Ing. Marc Schmidt, Dr.-Ing. Lothar Gail, Hugo Hemel MSc. Air filtration
More informationWHITE PAPER. Why your medical microelectronics development partner needs both particulateand microbial-controlled clean rooms
WHITE PAPER Why your medical microelectronics development partner needs both particulateand microbial-controlled clean rooms Microelectronics technology is increasingly ubiquitous, even within the human
More informationCurrent Trends in Sterile Manufacturing. by Sterling Kline, RA Director of Project Development Integrated Project Services (IPS)
Current Trends in Sterile Manufacturing by Sterling Kline, RA Director of Project Development Integrated Project Services (IPS) Executive Summary Drug developers go to great lengths to assure that their
More informationEmcure Pharmaceuticals Limited 3/3/16
1 of 7 05/06/2016 8:22 AM U.S. Food and Drug Administration Protecting and Promoting Your Health Emcure Pharmaceuticals Limited 3/3/16 Department of Health and Human Services Public Health Service Food
More informationHarmonizing FDA Regulation and the Practice of Pharmacy: Challenges and Opportunities. Plus an update on PET Drug User Fees
Harmonizing FDA Regulation and the Practice of Pharmacy: Challenges and Opportunities Plus an update on PET Drug User Fees Michael Nazerias - Vice President, RA/QA PETNET Solutions, Inc. (a Siemens Company)
More informationRisk Assessment and Preventive Measures Checklist for Construction and Renovation. Location of Construction: Project Start Date: Estimated Duration:
Risk Assessment and Preventive Measures Checklist for Construction and Renovation Location of Construction: Project Start Date: Estimated Duration: Project Manager (PM): Contractor(s): Infection Prevention
More informationResponding to an FDA 483
Responding to an FDA 483 Jim Melancon VP, Associate General Counsel BioScrip, Inc. Marc Stranz, PharmD Healthcare Consultant Disclosure The speakers declare no conflicts of interest or financial interest
More informationThe Parenteral Drug Association
C O N F E R E N C E R E P O R T Equipment Cleaning Microbial Control Issues By Destin A. LeBlanc, M.A. Cleaning Validation Technologies Validation: The Parenteral Drug Association (PDA) spring conference
More informationSemiconductor Manufacturing Facility Design
TM W W W. C E M A G. U S J U LY / A U G U S T 2 0 1 5 Semiconductor Manufacturing Facility Design Modular cleanrooms: An evolving industry ISO 14644 and biopharma monitoring Cleanrooms have a dirty little
More informationEnsuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education
Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education Loyd V. Allen, Jr., Ph.D. Professor & Chair Emeritus University of Oklahoma HSC College of Pharmacy Editor-in in-chief International
More information#1 Misalignment of internal and external resources
It must be remembered that there is nothing more difficult to plan, more doubtful of success, nor more dangerous to manage, than the creation of a new system. For the initiator has the enmity of all who
More informationImmobilization and Death of Bacteria by Flora Seal Microbial Sealant
International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 6718, ISSN (Print): 2319 670X Volume 6 Issue 6 June 2017 PP. 45-49 Immobilization and Death of Bacteria by Flora Seal Microbial
More informationASEPTIC BIOPHARMACEUTICAL MANUFACTURING: FAQs
ASEPTIC BIOPHARMACEUTICAL MANUFACTURING: FAQs THE BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER UNDERSTANDING, ACCELERATED REDUCE RISK INCREASE EFFICIENCY IMPROVE PROCESS UNDERSTANDING The BioTrak Real-Time
More informationGuidance for Industry
Guidance for Industry Sterile Drug Products Produced by Aseptic Processing Current Good Manufacturing Practice U.S. Department of Health and Human Services Food and Drug Administration Center for Drug
More informationDISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT
DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT by Dave Rottjakob, M.T. (ASCP) December, 2013 INTRODUCTION Obtaining the highest confidence that
More informationCleaning Procedures. These guidelines are intended for Bulk Pharmaceutical Chemicals but almost every word applies to Drug Products
CLEANING DEVELOPMENT Cleaning Procedures as the FDA See It These guidelines are intended for Bulk Pharmaceutical Chemicals but almost every word applies to Drug Products BPC CLEANING (& Drug Products)
More informationBiosafety Level 2 (BSL-2) Laboratory Guidelines
Biosafety Level 2 (BSL-2) Laboratory Guidelines Table of Contents 1. Introduction... 2 2. Required Document for BUA Application Process... 2 3. Training... 2 4. Signage... 2 5. Transporting Biohazardous
More informationInfection Control Risk Assessment Matrix of Precautions for Construction & Renovation
Figure 3-6. Sample ICRA Matrix of Precautions Infection Control Risk Assessment Matrix of Precautions for Construction & Renovation Step 1: Using the following table, identify the Type of Construction
More informationGuidelines for Selection and Use of Disinfectants
Guidelines for Selection and Use of Disinfectants Ref: (a) APIC Guidelines for Infection Control Practice, American Journal of Infection Control; April 1990, Vol 18, 99-113. To assist health care professionals
More informationMicrobiological Quality: Understanding Drinking Water Quality and Management
S A S K A T C H E W A N Microbiological Quality: Understanding Drinking Water Quality and Management June 2017 EPB 197 Table of Contents Page Number How to Determine the Microbiological Quality... 1 Monitoring
More informationPIGEON DROPPINGS CLEAN UP WORK TABLE OF CONTENTS
PIGEON DROPPINGS CLEAN UP WORK TABLE OF CONTENTS PAGE PIGEON DROPPINGS CLEAN UP WORK... 1 1 GENERAL... 1 1.1 GENERAL CONDITIONS AND RELATED WORK... 1 1.2 DESCRIPTION OF WORK... 1 1.3 DOCUMENTS TO BE SUBMITTED...
More informationWhile comprehensive, this document does not replace a thorough review of the Rule to assure proper compliance.
Introduction A documented and implemented SQF System goes a long way in preparing certified sites for enforcement. The FDA Produce Safety Rule (or Rule) has specific requirements that may go beyond what
More informationSterility Assurance Level and Aseptic Manufacturing Process in Pharmaceuticals
Review Article ISSN 2277-3657 Available online at www.ijpras.com Volume 3, Issue 4 (2014),10-15 International Journal of Pharmaceutical Research & Allied Sciences Sterility Assurance Level and Aseptic
More informationTHE SAFE DISPOSAL OF CLINICAL/DOMESTIC WASTE
Section V THE SAFE DISPOSAL OF CLINICAL/DOMESTIC WASTE The Trust is currently reviewing the requirements of the recent guidelines Health Technical Memorandum Safe Management of Healthcare Waste (HTML 07-01).
More informationUHV Cleanliness Requirements: Cleaning/Baking and Contamination Control
UHV Cleanliness Requirements: Cleaning/Baking and Contamination Control Dennis Coyne HAM-SAS Bidder s Conference @ LIGO Laboratory, Caltech 25 October 2005 Livingston, LA Hanford, WA LIGO R&D 1 Basic UHV
More informationMICROBIOLOGY AND NEW TECHNOLOGY HOW TECHNOLOGY CAN IMPACT ON MICROBIOLOGICAL CONTROL
MICROBIOLOGY AND NEW TECHNOLOGY HOW TECHNOLOGY CAN IMPACT ON MICROBIOLOGICAL CONTROL DISCUSSION AREAS HOW MICROBIOLOGY NEEDS TO CHANGE TO MEET FUTURE DEMANDS AND PRODUCTION SYSTEMS MICROBIOLOGY AND PAT
More informationBacterial Counts - Quantitative Analysis of Microbes
Bacterial Counts - Quantitative Analysis of Microbes Introduction: It is often important to know not only what types of bacteria are in a sample but also how many of them are present. Food manufacturers
More information